Edit Module

Aratana Enters Animal Health Industry With $20 Million In Funding

Posted: January 7, 2011, 5:30 p.m., EDT



Published:

Aratana Therapeutics of Kansas City, Kan., reported today that it has received $20 million in Series A financing, led by MPM Capital and Avalon Ventures.

The newly-formed company will focus on developing pharmaceutical therapies for the animal health industry.

“At Aratana, we will be focused on taking advancements from the human biopharmaceutical industry and applying them in new ways to treat and care for animals,” said David Rosen, DVM, president and founder of Aratana Therapeutics.

Specifically, Aratana will fund, develop and manage the clinical trials and development activities necessary to achieve regulatory approval, according to the Kansas Bioscience Authority, which awarded $1 million to the start-up company. The goal is to partner these products to animal health companies “that have a meaningful presence in the relevant sector of the animal health market.”

Aratana will welcome Linda Rhodes, VMD, Ph.D., as CEO in February. Previously, Dr. Rhodes was founder and vice president of clinical development at AlcheraBio, an entrepreneurial contract research organization focused on helping major animal health companies develop new drugs.

“My entire career has been devoted to developing therapies for animals, and I am looking forward to continuing that work in this exciting, venture-capital model at Aratana,” she said.

Aratana’s board of directors will include Rhodes; Steven St. Peter, MD, managing director at MPM Capital; Jay Lichter, managing director at Avalon Ventures; and Ron Meeusen, founder of Cultivian Ventures.

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Vets Perform Surgery on Panda Cub to Remove Mass of Bamboo in Intestine

The emergency bowel obstruction surgery saved the life of Bei Bei, a giant panda cub at the Smithsonian National Zoo.

Which Vet Tech School is Best? Community for Accredited Online Schools Ranks Each One

Does your school make the list?

AVMA Report Says Market for Vets is still 'Robust'

The "2016 AVMA Report on the Market for Veterinarians" looked at a number of factors, including employment, income and health.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module